SEC Form 4 · accession 0001962926-26-000008
Structure Therapeutics Inc. · GPCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xichen Lin
Officer — CHIEF SCIENTIFIC OFFICER
Period of report
Aug 18, 2026
Accepted (ET)
Aug 19, 2026 · 8:23 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001888886
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 18, 2026 | M | 11,817 | $0.34 | A | 240,777 | D | |
| Ordinary SharesF2 | Aug 18, 2026 | C | 11,817 | $0.00 | D | 228,960 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (right to buy)F4,F1,F3 | $0.34 | Aug 18, 2026 | M | 11,817 | D | — | Sep 10, 2029 | Ordinary Shares | 11,817 | 142,898 | D |
| American Depositary SharesF6,F5 | — | Aug 18, 2026 | C | 3,939 | A | — | — | Ordinary Shares | 11,817 | 3,939 | D |
| American Depositary SharesF8,F9,F5 | — | Aug 18, 2026 | S | 3,020 | D | — | — | Ordinary Shares | 9,060 | 919 | D |
| American Depositary SharesF8,F10,F5 | — | Aug 18, 2026 | S | 519 | D | — | — | Ordinary Shares | 1,557 | 400 | D |
| American Depositary SharesF8,F11,F5 | — | Aug 18, 2026 | S | 400 | D | — | — | Ordinary Shares | 1,200 | 0 | D |
Explanation of responses
- F1Reflects price per share in Ordinary Shares.
- F10The weighted average sale price for the transaction reported was $54.1970, and the range of prices were between $53.80 and $54.7950. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.
- F11The weighted average sale price for the transaction reported was $55.05 and the range of prices were between $54.85 and $55.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.
- F2The Ordinary Shares were converted into American Depositary Shares as reported in Table II.
- F31/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
- F4This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 11,817 Ordinary Shares.
- F5Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
- F611,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 3,939 American Depositary Shares.
- F7The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026.
- F8Reflects price per share in American Depositary Shares.
- F9The weighted average sale price for the transaction reported was $53.133 and the range of prices were between $52.77 and $53.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.